Open AccessSafety and Tolerability of Remdesivir in Patients with End-stage Renal Disease on Maintenance Hemodialysis
Author(s) -
Maulin Shah,
Premlata Mital,
Dhavalkumar Prajapati,
Punam Bhende,
Abhishek Prajapati,
Sunil H Chhajwani,
Krushan Yajnik,
Jaishree Ganjiwale,
Jyoti Mannari,
Bhalendu Vaishnav
Publication year - 2022
Publication title -
indian journal of critical care medicine/indian journal of critical care medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.317
H-Index - 30
eISSN - 1998-359X
pISSN - 0972-5229
DOI - 10.5005/jp-journals-10071-24168
Subject(s) - medicine , tolerability , dialysis , end stage renal disease , acute kidney injury , oxygen saturation , retrospective cohort study , hemodialysis , diabetes mellitus , renal function , adverse effect , chemistry , organic chemistry , oxygen , endocrinology
The use of remdesivir is not recommended in patients with end-stage renal disease (ESRD) with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection unless potential advantage offset disadvantage due to limited safety data. Our objective was to assess the safety of remdesivir in patients with end-stage renal failure and evaluate the outcome of this vulnerable group.